# OnCo record ibi343 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ibi343/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ibi343" ;
  schema:name "IBI343"@en ;
  schema:description "IBI343 is an experimental investigational agent whose form is not stated in the registry from Innovent Biologics (Suzhou) in phase 3 trials for pancreatic ductal adenocarcinoma, aimed at Claudin 18.2."@en ;
  schema:url <https://onco.cc/drugs/ibi343/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=IBI343> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "antibody-drug conjugate (ADC), per the sponsor's pipeline page; form not stated in the registry record" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:targets <https://onco.cc/targets/cldn18-2/> ;
  onco:companies <https://onco.cc/companies/innovent/> ;
  onco:trials <https://onco.cc/trials/g-hope-002/>, <https://onco.cc/trials/nct07483554/> .